Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Use of MRI and PET for Assessing Disease Activity in Takayasu`s Arteritis

Study:

VCRC Imaging Protocol for Magnetic Resonance and Positron Emission Tomography in Large-vessel Vasculitis (Takayasu`s Arteritis):Development as Clinical Trial Outcome Measures

Rationale:

n/a

Purpose:

Assessing disease activity in people with Takayasu`s arteritis is difficult, as most people with the disease do not exhibit visible, measurable symptoms. Combination positron emission tomography/computed axial tomography (PET/CT) is a particularly sensitive, accurate scanning method that may improve researchers` ability to evaluate people with the disease. This study will determine the effectiveness of PET/CT in assessing disease activity in people with Takayasu`s arteritis.

Study Status: Recruiting

Recruiting:
Katie Gartner 216-445-1397 gartnek@ccf.org

Condition Intervention Phase
Takayasu Arteritis n/a N/A

Verified by Peter Merkel November, 2013

Sponsored by: Peter Merkel
Information provided by: University of Pennsylvania
ClinicalTrials.gov identifier: NCT00744952

Study Type: Interventional

Study Design: Observational Model: Cohort, Time Perspective: Prospective

Cleveland Clinic Foundation
Cleveland, Ohio 44195
United States

Peter A. Merkel, MD, MPH., Study Chair

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site